Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Acologix expands AC-100 phase II development for periodontal bone loss

May 30, 2005

Acologix advances AC-100 into phase II in dentistry

May 10, 2005

BioMimetic's GEM-21S recommended for approval

July 20, 2004

PMA for GEM-21S accepted for review

May 7, 2004

Enrollment under way in phase III Periostat MR study for adult periodontitis

April 13, 2004

BioMimetic Pharmaceuticals and Luitpold Pharmaceuticals establish alliance

Jan. 14, 2004

Inhibitors of Arg- and Lys-gingipain and their use in periodontitis therapy

June 20, 2003

Periostat approved in Canada

April 8, 2003

New data on subantimicrobial doses of Periostat discussed in San Antonio

March 25, 2003

Arestin approved in Sweden

Jan. 24, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...